- Report
- January 2024
- 200 Pages
Global
From €4006EUR$4,150USD£3,436GBP
- Report
- February 2021
- 360 Pages
United States
From €2316EUR$2,400USD£1,987GBP
- Report
- November 2023
- 35 Pages
Global
From €5617EUR$5,820USD£4,819GBP
Viracept is an antiviral drug used to treat HIV infection. It is a protease inhibitor, meaning it blocks the action of the HIV protease enzyme, which is necessary for the virus to replicate. Viracept is used in combination with other antiretroviral drugs to treat HIV infection. It is also used to prevent HIV infection in people who have been exposed to the virus.
The market for Viracept is part of the larger market for infectious diseases drugs. This market includes drugs used to treat a wide range of infectious diseases, including HIV, hepatitis, tuberculosis, and malaria. The market is highly competitive, with many companies offering similar products.
Some of the companies in the Viracept market include AbbVie, Gilead Sciences, Merck, and Pfizer. Show Less Read more